SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337349.
  • 2
    Baron JA, Karagas M, Barrett J, Kniffin W, Malenka D, Mayor M, Keller RB 1996 Basic epidemiology of fractures of the upper and lower limb among Americans over 65 years of age. Epidemiology 7:612618.
  • 3
    Delmas PD 1995 Biochemical markers for the assessment of bone turnover. In: RiggsBL, MeltonLJIII (eds.) Osteoporosis: Etiology, Diagnosis, and Management. Lippincott-Raven, Philadelphia, PA, USA.
  • 4
    Fatayerji D, Eastell R 1999 Age-related changes in bone turnover in men. J Bone Miner Res 14:12031210.
  • 5
    Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationships of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:22662274.
  • 6
    Orwoll ES, Deftos LJ 1990 Serum osteocalcin (BGP) levels in normal men: A longitudinal evaluation reveals an age-associated increase. J Bone Miner Res 5:259262.
  • 7
    Orwoll ES, Bell NH, Nanes MS, Flessland KA, Pettinger MB, Mallinak NJS, Cain DF 1998 Collagen N-telopeptide excretion in men: The effects of age and intrasubjects variability. J Clin Endocrinol Metab 83:39303035.
  • 8
    Schneider DL, Barrett-Connor EL 1997 Urinary N-telopeptide levels discriminate normal, osteopenic and osteoporotic bone mineral density. Arch Intern Med 157:12411245.
  • 9
    Chandani AK, Scariano JK, Glew RH, Clemens JD, Garry PJ, Baumgartner RN 2000 Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men. Bone 26:513518.
  • 10
    Gallagher JC, Kinyamu HK, Fowler SE, Dawson-Hughes B, Dlasky GP, Sherman SS 1998 Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 13:475482.
  • 11
    Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J 1996 Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 42:947954.
  • 12
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ 1994 Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:16431649.
  • 13
    Sone T, Miyake M, Takeda N, Fukunaga M 1995 Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: Age- and sex-related changes and reference limits. Bone 17:35339.
  • 14
    Yoshimura N, Hashimoto T, Sakata K, Morioka S, Kasamatsu T, Cooper C 1999 Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: The Taiji Study. Calcif Tissue Int 65:198202.
  • 15
    Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BEC 1995 Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf) 42:141146.
  • 16
    Dennison E, Eastell R, Fall CHD, Kellingray S, Wood PJ, Cooper C 1999 Determinants of bone loss in elderly men and women: A prospective population-based study. Osteoporos Int 10:384391.
  • 17
    Krall EA, Dawson-Hughes B, Hirst K, Gallagher JC, Sherman SS, Dalsky G 1997 Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women. J Gerontol A Biol Sci Med Sci 52A:M61M67.
  • 18
    Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD 1992 Measurement of serum osteocalcin with human-specific two-site immunoradiometric assay. J Bone Miner Res 7:13891398.
  • 19
    Gomez B Jr., Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT 1995 Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:15601566.
  • 20
    Garnero P, Gineyts E, Riou JP, Delmas PD 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780785.
  • 21
    Pedersen BJ, Ravn P, Bonde M 1998 Type I collagen C-telopeptide degradation products as bone resorption markers. J Clin Ligand Assay 21:118127.
  • 22
    Fledelius C, Johnsen AH, Cloos PAC, Bonde M, Qvist P 1997 Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerizes Asp-Gly sequence within the C-terminal telopeptide (α1) region. J Biol Chem 272:97559763.
  • 23
    Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, Herling C, Qvist P, Christiansen C 1998 Clinical evaluation of the serum CrossLaps one step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem 44:22902300.
  • 24
    Rosenquist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P, Christiansen C 1998 Serum CrossLaps one step ELISA. First application of monoclonal antobodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 44:22812289.
  • 25
    Szulc P, Marchand F, Dubeouf F, Delmas PD 2000 Cross-sectional assessment of age-related bone loss in men: The MINOS Study. Bone 26:123129.
  • 26
    Minisola S, Pacitti MT, Romagnoli E, Rosso R, Carnevale V, Caravella P, Scillitani A, Dicembrino F 1999 Clinical validation of a new immunoradiometric assay for intact human osteocalcin. Calcif Tissue Int 64:365369.
  • 27
    Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:12511258.
  • 28
    Ross PD, Knowlton W 1998 Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297302.
  • 29
    Sherman SS, Tobin JD, Hollis BW, Gundberg CM, Roy TA, Plato CC 1992 Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res 7:11231130.
  • 30
    Woitge HW, Scheidt-Nave C, Kissling C, Leidig-Bruckner G, Meyer K, Grauer A, Scharla SH, Ziegler R, Seibel MJ 1998 Seasonal variation of biochemical indexes of bone turnover: Results of a population-based study. J Clin Endocrinol Metab 83:6875.
  • 31
    Tenover JS 1992 Effects of testosterone supplementation in the aging male. 75:10921098.
  • 32
    Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:10461053.
  • 33
    Knott L, Bailey AJ 1998 Collagen cross-links in mineralizing tissues: A review of their chemistry, function, and clinical relevance. Bone 22:181187.
  • 34
    Colwell A, Eastell R 1996 The renal clearance of free and conjugated pyridinium cross-links of collagen. J Bone Miner Res 11:19761980.
  • 35
    Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F 1993 Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 8:643648.
  • 36
    Kenny AM, Gallagher JC, Prestwood KM, Gruman CA, Raisz LG 1998 Bone density, bone turnover, and hormone levels in men over age 75. J Gerontol A Biol Sci Med Sci 53A:M419M425.
  • 37
    Cloos P, Fledelius C 1998 Two new bone resorption assays measuring racemized protein fragments: Measurement of age-modified peptides to assess bone quality. Bone 23(Suppl):S230.(abstract T114)
  • 38
    Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T 1999 The relationships between the degree of β-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures. Osteoporos Int 9:405409.
  • 39
    Takahashi M, Hoshino H, Kushida K 1999 Measurements of urinary nonisomerized form of type I collagen degradation products (α-CTX) in aging, menopause, and osteoporosis with fractures. Clin Chim Acta 279:6976.
  • 40
    Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C 1991 Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639644.
  • 41
    De Laet CEDG, Van Hout BA, Burger H, Weel AEAM, Hofman A, Pols HAP 1998 Hip fracture prediction in elderly men and women: Validation in the Rotterdam study. J Bone Miner Res 13:15871593.
  • 42
    Szulc P, Munoz F, Garnero P, Marchand F, Duboeuf F, Delmas PD 2000 Increased bone resorption in moderate smokers: The MINOS study. J Bone Miner Res 15:S1;S168.(abstract 1119)
  • 43
    Ho YV, Frauman AG, Thomson W, Seeman E 2000 Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98101.
  • 44
    Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P 2000 Alendronate treatment of osteoporosis in men. N Engl J Med 343:604610.